Climb Bio, Inc.
CLYM
$2.33
-$0.15-6.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.62M | 19.19M | 15.41M | 12.39M | 9.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.00M | 47.04M | 27.02M | 19.17M | 15.55M |
| Operating Income | -53.00M | -47.04M | -27.02M | -19.17M | -15.55M |
| Income Before Tax | -46.76M | -92.98M | -73.90M | -69.12M | -64.20M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -46.76 | -92.98 | -73.90 | -69.12 | -64.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.76M | -92.98M | -73.90M | -69.12M | -64.20M |
| EBIT | -53.00M | -47.04M | -27.02M | -19.17M | -15.55M |
| EBITDA | -10.66M | -- | -- | -- | -- |
| EPS Basic | -0.70 | -2.38 | -2.13 | -2.13 | -2.15 |
| Normalized Basic EPS | -0.42 | -0.41 | -0.25 | -0.25 | -0.28 |
| EPS Diluted | -0.70 | -2.38 | -2.13 | -2.13 | -2.15 |
| Normalized Diluted EPS | -0.42 | -0.41 | -0.25 | -0.25 | -0.28 |
| Average Basic Shares Outstanding | 266.80M | 229.56M | 189.74M | 152.54M | 112.60M |
| Average Diluted Shares Outstanding | 266.80M | 229.56M | 189.74M | 152.54M | 112.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |